首页 >
法规速递
-
Scientific guideline: Guideline on the calculation of dose factor to be submitted to the Union Product Database (UPD)-2023/10/13
2023-10-16查看详情 > -
ICH guideline E19 on a selective approach to safety data collection in specific late-stage pre-approval or post-approval clinical trials - Scientific guideline (updated)-2023/10/6
2023-10-07查看详情 > -
Regulatory and procedural guideline: Guidance on handling scientific committee/other (scientific) expert group member’s declared intention to become an employee in a pharmaceutical company, a medical device company or in the biotechnology sector (updated)
2023-10-07查看详情 > -
Regulatory and procedural guideline: European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure (updated)-2023/9/29
2023-10-07查看详情 > -
Regulatory and procedural guideline: European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes (updated)-2023/9/29
2023-10-07查看详情 > -
Scientific guideline: Draft guideline on clinical investigation of medicinal products in the treatment of depression - Revision 3-2023/9/15
2023-09-15查看详情 > -
Draft Guidance: Clinical Pharmacology Considerations for Peptide Drug Products-2023/9/8
2023-09-14查看详情 > -
Scientific guideline: DRAFT qualification opinion for GFR slope as a Surrogate Endpoint in RCT for CKD-2023/9/6
2023-09-07查看详情 > -
Regulatory and procedural guideline: Member states contact points for translations review (updated)-2023/8/30
2023-09-01查看详情 > -
Regulatory and procedural guideline: Guidance to applicants/marketing authorisation holders on oral explanations at European Medicines Agency-2023/8/8
2023-08-09查看详情 >